8049 — Jilin Province Huinan Changlong Bio-pharmacy Co Share Price
- HK$1.06bn
- HK$567.72m
- CNY881.16m
- 78
- 95
- 75
- 96
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.54 | ||
Price to Tang. Book | 0.54 | ||
Price to Free Cashflow | 4.21 | ||
Price to Sales | 1 | ||
EV to EBITDA | 1.95 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 12.52% | ||
Return on Equity | 11.85% | ||
Operating Margin | 23.74% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 622.25 | 705.46 | 841.59 | 841.54 | 881.16 | n/a | n/a | 6.41% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -11.93 | +12.43 | +45.75 | -26.96 | +20.82 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a China-based company principally engaged in the manufacture and distribution of traditional Chinese medicines and pharmaceutical products. The Company primarily sells its products under the Changlong and Qingtong brands. The Company's main products include Hai Kun Shen Xi Jiao Nang, small volume solution, lyophilized powder for injection, power for injection, active pharmaceutical ingredient, sterile active pharmaceutical ingredient, solid pharmacy biochemical drugs and others. The Company also makes short-term investments in the wealth management products. The Company mainly operates its businesses in the domestic market.
Directors
- Bao Gang Zhao CFO (48)
- Hong Zhang CCO (60)
- Xiao Guang Zhang EDR (51)
- Guo Wen Wu EDR (50)
- Ze Shu Yang OTH (47)
- Sai Cheong Mok SEC (35)
- Jun Gui Bai NID (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 19th, 1996
- Public Since
- May 24th, 2001
- No. of Employees
- 745
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 560,250,000

- Address
- No. 31 Beishan Street, TONGHUA, 135100
- Web
- http://www.jlchanglong.com
- Phone
- +86 4358218333
- Auditors
- Prism Hong Kong and Shanghai Limited
Upcoming Events for 8049
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Annual Shareholders Meeting
Half Year 2025 Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Earnings Release
Similar to 8049
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 21:28 UTC, shares in Jilin Province Huinan Changlong Bio-pharmacy Co are trading at HK$1.67. This share price information is delayed by 15 minutes.
Shares in Jilin Province Huinan Changlong Bio-pharmacy Co last closed at HK$1.67 and the price had moved by -5.21% over the past 365 days. In terms of relative price strength the Jilin Province Huinan Changlong Bio-pharmacy Co share price has underperformed the FTSE Developed Asia Pacific Index by -4.13% over the past year.
There is no consensus recommendation for this security.
Find out moreJilin Province Huinan Changlong Bio-pharmacy Co does not currently pay a dividend.
Jilin Province Huinan Changlong Bio-pharmacy Co does not currently pay a dividend.
Jilin Province Huinan Changlong Bio-pharmacy Co does not currently pay a dividend.
To buy shares in Jilin Province Huinan Changlong Bio-pharmacy Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$1.67, shares in Jilin Province Huinan Changlong Bio-pharmacy Co had a market capitalisation of HK$1.06bn.
Here are the trading details for Jilin Province Huinan Changlong Bio-pharmacy Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 8049
Based on an overall assessment of its quality, value and momentum Jilin Province Huinan Changlong Bio-pharmacy Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jilin Province Huinan Changlong Bio-pharmacy Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +22.04%.
As of the last closing price of HK$1.67, shares in Jilin Province Huinan Changlong Bio-pharmacy Co were trading +16.23% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Jilin Province Huinan Changlong Bio-pharmacy Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.67.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Jilin Province Huinan Changlong Bio-pharmacy Co's management team is headed by:
- Bao Gang Zhao - CFO
- Hong Zhang - CCO
- Xiao Guang Zhang - EDR
- Guo Wen Wu - EDR
- Ze Shu Yang - OTH
- Sai Cheong Mok - SEC
- Jun Gui Bai - NID